• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人CD25 + CD4 + T抑制细胞克隆产生转化生长因子β,但不产生白细胞介素10,且不同于1型调节性T细胞。

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

作者信息

Levings Megan K, Sangregorio Romina, Sartirana Claudia, Moschin Anna Lisa, Battaglia Manuela, Orban Paul C, Roncarolo Maria-Grazia

机构信息

San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Via Olgettina 58, Milan 20132, Italy.

出版信息

J Exp Med. 2002 Nov 18;196(10):1335-46. doi: 10.1084/jem.20021139.

DOI:10.1084/jem.20021139
PMID:12438424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2193983/
Abstract

T regulatory (Tr) cells are essential for the induction of peripheral tolerance. Several types of Tr cells exist, including CD4(+) T cells which express CD25 constitutively and suppress immune responses via direct cell-to-cell interactions, and type 1 T regulatory (Tr1) cells, which function via secretion of interleukin (IL)-10 and transforming growth factor (TGF)-beta. The relationship between CD25(+)CD4(+) T cells and Tr1 cells remains unclear. Here, we demonstrate at the clonal level that Tr1 and CD25(+)CD4(+) T cells are two distinct subsets of regulatory cells with different cytokine production profiles. Furthermore, CD25(-)CD4(+) T cells can be rendered anergic by IL-10 and differentiated into Tr1 cells in the absence of CD25(+)CD4(+) T cells. Cloned human CD25(+)CD4(+) T cell populations are heterogeneous and only a subset of clones continues to express high levels of CD25 and is suppressive. The intensity of CD25, cytotoxic T lymphocyte antigen (CTLA)-4, and glucocorticoid-induced tumor necrosis factor (TNF) receptor expression correlates with the suppressive capacity of the T cell clones. None of the CD25(+)CD4(+) T cell clones with suppressive function produce IL-10, but all produce TGF-beta. Suppression mediated by CD25(+)CD4(+) T cell clones is partially dependent on TGF-beta, but not on constitutive high expression of CD25. Together these data indicate that naturally occurring human CD25(+)CD4(+) T cells are distinct from IL-10-producing Tr1 cells.

摘要

调节性T(Tr)细胞对于诱导外周耐受至关重要。存在几种类型的Tr细胞,包括组成性表达CD25并通过直接细胞间相互作用抑制免疫反应的CD4(+) T细胞,以及通过分泌白细胞介素(IL)-10和转化生长因子(TGF)-β发挥作用的1型调节性T(Tr1)细胞。CD25(+)CD4(+) T细胞与Tr1细胞之间的关系仍不清楚。在此,我们在克隆水平上证明Tr1细胞和CD25(+)CD4(+) T细胞是调节性细胞的两个不同亚群,具有不同的细胞因子产生谱。此外,CD25(-)CD4(+) T细胞可被IL-10诱导无反应性,并在不存在CD25(+)CD4(+) T细胞的情况下分化为Tr1细胞。克隆的人CD25(+)CD4(+) T细胞群体是异质性的,只有一部分克隆继续高水平表达CD25并具有抑制作用。CD25、细胞毒性T淋巴细胞抗原(CTLA)-4和糖皮质激素诱导的肿瘤坏死因子(TNF)受体的表达强度与T细胞克隆的抑制能力相关。具有抑制功能 的CD25(+)CD4(+) T细胞克隆均不产生IL-10,但均产生TGF-β。CD25(+)CD4(+) T细胞克隆介导的抑制作用部分依赖于TGF-β,但不依赖于CD25的组成性高表达。这些数据共同表明,天然存在的人CD25(+)CD4(+) T细胞与产生IL-10的Tr1细胞不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/5c032d3141b2/20021139f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/6f26c2177022/20021139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/c5e045e7906e/20021139f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/0a4e9fcb1816/20021139f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/b417f635f32b/20021139f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/28f29cc8b1ec/20021139f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/09122ccc4d4e/20021139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/b4bfe4922ab2/20021139f7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/5c032d3141b2/20021139f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/6f26c2177022/20021139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/c5e045e7906e/20021139f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/0a4e9fcb1816/20021139f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/b417f635f32b/20021139f4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/28f29cc8b1ec/20021139f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/09122ccc4d4e/20021139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/b4bfe4922ab2/20021139f7a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a3/2193983/5c032d3141b2/20021139f8.jpg

相似文献

1
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.人CD25 + CD4 + T抑制细胞克隆产生转化生长因子β,但不产生白细胞介素10,且不同于1型调节性T细胞。
J Exp Med. 2002 Nov 18;196(10):1335-46. doi: 10.1084/jem.20021139.
2
Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.人CD25(+)CD4(+)调节性T细胞可抑制初始和记忆性T细胞增殖,并且能够在体外扩增而不丧失功能。
J Exp Med. 2001 Jun 4;193(11):1295-302. doi: 10.1084/jem.193.11.1295.
3
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.人无反应性/抑制性CD4(+)CD25(+) T细胞:一个高度分化且易于凋亡的群体。
Eur J Immunol. 2001 Apr;31(4):1122-31. doi: 10.1002/1521-4141(200104)31:4<1122::aid-immu1122>3.0.co;2-p.
4
Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.在转化生长因子-β共刺激的CD4+CD25-T细胞中获得无反应性和抑制活性。
Int Immunol. 2004 Aug;16(8):1203-13. doi: 10.1093/intimm/dxh123. Epub 2004 Jul 5.
5
CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.CD4+ CD25+ [校正后] 调节性T细胞使初始CD4+ CD25- T细胞失能并具有抑制作用。
Immunology. 2007 Apr;120(4):447-55. doi: 10.1111/j.1365-2567.2007.02544.x. Epub 2007 Jan 17.
6
CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.由白细胞介素-10处理的人树突状细胞诱导产生的CD4(+)和CD8(+)无反应性T细胞表现出抗原特异性抑制活性。
Blood. 2002 Apr 1;99(7):2468-76. doi: 10.1182/blood.v99.7.2468.
7
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.CD4(+)CD25(+) 人胸腺细胞的表型、定位及抑制机制
J Exp Med. 2002 Aug 5;196(3):379-87. doi: 10.1084/jem.20020110.
8
CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.CD4(+)CD25(+) T细胞促进T细胞无能的诱导。
J Immunol. 2001 Oct 15;167(8):4271-5. doi: 10.4049/jimmunol.167.8.4271.
9
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.树突状细胞部分消除了人外周血中存在的CD4+CD25+ T细胞的调节活性。
Int Immunol. 2007 Mar;19(3):227-37. doi: 10.1093/intimm/dxl139. Epub 2007 Feb 7.
10
Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.通过口服抗原激活CD25(+)CD4(+)调节性T细胞。
J Immunol. 2001 Oct 15;167(8):4245-53. doi: 10.4049/jimmunol.167.8.4245.

引用本文的文献

1
Armored human CAR T cells with PD1 promoter-driven IL-10 have enhanced suppressive function.具有PD1启动子驱动的IL-10的装甲人类嵌合抗原受体T细胞具有增强的抑制功能。
Sci Adv. 2025 Jun 13;11(24):eadx7845. doi: 10.1126/sciadv.adx7845.
2
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.从承诺到实践:嵌合抗原受体T细胞疗法与调节性T细胞疗法在自身免疫性疾病及其他免疫介导疾病中的应用
Front Immunol. 2024 Dec 4;15:1509956. doi: 10.3389/fimmu.2024.1509956. eCollection 2024.
3
Tregs in transplantation tolerance: role and therapeutic potential.

本文引用的文献

1
Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines.人1型调节性T细胞的生长和扩增独立于TCR激活,但需要外源性细胞因子。
Eur J Immunol. 2002 Aug;32(8):2237-45. doi: 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2.
2
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.CD4(+)CD25(+) 人胸腺细胞的表型、定位及抑制机制
J Exp Med. 2002 Aug 5;196(3):379-87. doi: 10.1084/jem.20020110.
3
Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.
调节性T细胞在移植耐受中的作用及治疗潜力。
Front Transplant. 2023 Aug 30;2:1217065. doi: 10.3389/frtra.2023.1217065. eCollection 2023.
4
Preparation and application of fluorescent monoclonal antibodies recognizing goat CD4CD25 regulatory T cells.制备及应用荧光标记的单克隆抗体识别山羊 CD4CD25 调节性 T 细胞。
Appl Microbiol Biotechnol. 2024 May 8;108(1):327. doi: 10.1007/s00253-024-13115-4.
5
A Novel Role for the Soluble Isoform of CTLA-4 in Normal, Dysplastic and Neoplastic Oral and Oropharyngeal Epithelia.细胞毒性T淋巴细胞相关抗原4可溶性异构体在正常、发育异常及肿瘤性口腔和口咽上皮中的新作用
Cancers (Basel). 2023 Mar 10;15(6):1696. doi: 10.3390/cancers15061696.
6
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective.临床过继性调节性T细胞疗法:现状、挑战与展望。
Front Cell Dev Biol. 2023 Jan 30;10:1081644. doi: 10.3389/fcell.2022.1081644. eCollection 2022.
7
Effect of IL-27, Teriflunomide and Retinoic Acid and Their Combinations on CD4 T Regulatory T Cells-An In Vitro Study.白细胞介素 27、特立氟胺和维甲酸及其组合对 CD4+T 调节性 T 细胞的影响:一项体外研究。
Molecules. 2022 Dec 2;27(23):8471. doi: 10.3390/molecules27238471.
8
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation.Foxp3+ 调节性 T 细胞治疗自身免疫和实体器官移植中的免疫耐受。
Front Immunol. 2022 Nov 17;13:1055466. doi: 10.3389/fimmu.2022.1055466. eCollection 2022.
9
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.核因子κB受体激活剂(RANK)赋予急性髓系白血病对化疗的抗性并与不良病程相关。
Cancers (Basel). 2021 Dec 4;13(23):6122. doi: 10.3390/cancers13236122.
10
The Role of Innate and Adaptive Immune Cells in Skeletal Muscle Regeneration.先天免疫和适应性免疫细胞在骨骼肌再生中的作用。
Int J Mol Sci. 2021 Mar 23;22(6):3265. doi: 10.3390/ijms22063265.
感染性耐受:人类CD25(+)调节性T细胞将抑制活性传递给传统CD4(+)辅助性T细胞。
J Exp Med. 2002 Jul 15;196(2):255-60. doi: 10.1084/jem.20020394.
4
Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].人CD4(+)CD25(+)调节性接触依赖性T细胞诱导产生白细胞介素10的接触非依赖性1型样调节性T细胞[已校正] 。
J Exp Med. 2002 Jul 15;196(2):247-53. doi: 10.1084/jem.20020642.
5
CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.CD4(+)CD25(+)调节性T细胞可在不产生及不响应转化生长因子β1的情况下介导抑制功能。
J Exp Med. 2002 Jul 15;196(2):237-46. doi: 10.1084/jem.20020590.
6
CD4+ CD25+ suppressor T cells: more questions than answers.CD4+ CD25+ 抑制性T细胞:问题多于答案。
Nat Rev Immunol. 2002 Jun;2(6):389-400. doi: 10.1038/nri821.
7
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.CD4(+)CD25(+)免疫调节性T细胞:基因表达分析揭示糖皮质激素诱导的肿瘤坏死因子受体的功能作用
Immunity. 2002 Feb;16(2):311-23. doi: 10.1016/s1074-7613(02)00280-7.
8
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.通过糖皮质激素诱导的肿瘤坏死因子受体(GITR)刺激CD25(+)CD4(+)调节性T细胞会破坏免疫自身耐受性。
Nat Immunol. 2002 Feb;3(2):135-42. doi: 10.1038/ni759. Epub 2002 Jan 22.
9
Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.分泌转化生长因子β的Th3调节性细胞的诱导及作用机制
Immunol Rev. 2001 Aug;182:207-14. doi: 10.1034/j.1600-065x.2001.1820117.x.
10
Control of intestinal inflammation by regulatory T cells.调节性T细胞对肠道炎症的控制。
Immunol Rev. 2001 Aug;182:190-200. doi: 10.1034/j.1600-065x.2001.1820115.x.